The Internal Toxin Sparking America’s Silent Heart Crisis
In the last post, we exposed a major medical misconception: the belief that metformin damages the kidneys.
Slow Aging and Delay Chronic Disease Development
"Your body is the most complex machine you own, but it didn’t come with instructions. I'm writing the Owner's Manual."
Live Last read · last published · next check
Latest posts
The Metformin Myth and the Silent Kidney Crisis
Metformin blocks a root cause of chronic kidney disease
The CKD Paradox: Why Most Kidney Patients Die of Heart Attacks—and the Hidden Toxin Driving the Crisis
In clinical medicine, there is a stark, tragic paradox that every doctor knows, but few patients ever hear:
Her Doctor Told Her Metformin Hurts Your Kidney: Her Doctor was Wrong.
A close friend recently visited their doctor and asked if they could be started on metformin.
When Margin Throws Mission Under the Bus: The $100 Million Lesson in Systemic Healthcare Negligence
For self-insured employers, CFOs, and health plan fiduciaries, the search for meaningful healthcare cost containment usually leads to a familiar maze of point solutions, wellness apps, narrow networks, or benefit cuts.
How the Medical-Industrial Complex Overwrote Evidence-Based Medicine—And Why Fiduciaries Must Push Back
In our previous post, we detailed the remarkable economic pivot of the mid-2000s: Big Pharma quietly abandoned basic cardiovascular and metabolic drug development because first-generation “wonder drugs”—metformin, statins, ACE inhibitors, ARBs, eplerenone, and aspirin—set a clinical and economic bar that new, expensive single-molecule drugs simply could not beat.
Big Pharma Predicted Today’s Healthcare Crisis Decades Ago—And Then Capitalized On It
In an earlier post, The Leading Diabetes Drugs: One-Fourth the Benefit at Twenty Times the Cost, we examined a staggering mathematical reality: modern, heavily marketed single-molecule therapies and expensive specialty drugs routinely deliver a fraction of
The $4 Trillion Sinking Ship: Why American Healthcare Is Bankrupting Your Organization—
And How Precision Protocol Architecture Fixes the Model
When the System Collapses: A Real-World Story of Metabolic Multimorbidity
In our last two posts, we examined population data from nearly 150,000 rheumatology patients showing that 57.5% suffer from Chronic Overlapping Pain Conditions (COPCs) like fibromyalgia, chronic back pain, and irritable bowel syndrome.
Chronic Kidney Disease, ADMA, and the Risk of Heart Attack and Stroke
Metformin Protects You
These are People I Work With at Performance Health Collaborative.
Check out this video!